Angiosome-targeted vs non-targeted endovascular revascularization in diabetic foot ischemia: A retrospective cohort study
Angiosom-gezielte versus nicht gezielte endovaskuläre Revaskularisation bei diabetischer Fußischämie: retrospektive Kohortenstudie
World Journal of Diabetes · 15.11.2026 · 17 (11)
DOI: 10.4239/wjd.124667 ↗Auf einen Blick
Bei 142 Patient:innen mit diabetischer Fußischämie zeigte die angiosom-gezielte Revaskularisation keine besseren Ergebnisse als die nicht gezielte Revaskularisation. Wundheilung und Extremitätenerhalt unterschieden sich nicht signifikant.
Fragestellung
Ist eine angiosom-gezielte endovaskuläre Revaskularisation bei diabetischer Fußischämie mit besserer Wundheilung und besserem Extremitätenerhalt verbunden als eine nicht gezielte Revaskularisation?
Methode
Retrospektive monozentrische Kohortenstudie bei Patient:innen mit diabetischer Fußischämie nach endovaskulärer Revaskularisation; Vergleich von targeted-only, non-targeted-only und kombiniert. Primäre Endpunkte: Wundheilung und Extremitätenerhalt.
Ergebnisse
142 Patient:innen; Alter 65,4 ± 12,0 Jahre; 69,7 % männlich. Wundheilung: 48,5 % vs. 51,4 % vs. 41,2 % (P = 0,617); Extremitätenerhalt: 75,8 % vs. 76,7 % vs. 80,0 % (P = 0,903).
Einschränkungen
Retrospektives Design und moderate Stichprobengröße.
Schlussfolgerung der Autor:innen
Die Studie fand keinen statistisch signifikanten Zusammenhang zwischen angiosom-gezielter Revaskularisation und Wundheilung oder Extremitätenerhalt im Vergleich zur nicht gezielten Revaskularisation.
Kernaussagen
- Keine signifikanten Unterschiede bei Wundheilung
- Keine signifikanten Unterschiede beim Extremitätenerhalt
- Wundschwere und Follow-up waren wichtige Prädiktoren
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Kohortenstudie in der Zeitschrift World Journal of Diabetes, online erschienen am 15.11.2026. Verfasst von Sohaib Zoghoul und 9 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben.
Themen: Diabetisches Fußsyndrom
Abstract (Originalsprache)
BACKGROUND Diabetic foot ischemia is a severe macrovascular complication of peripheral artery disease that critically restricts blood flow to the lower extremities, severely compromising wound healing and increasing the risk of major amputation. These high-risk patients require urgent vascular imaging and revascularization. Advanced endovascular methods are used to address the complex anatomical challenges of the ischemic diabetic foot. AIM To evaluate whether angiosome-targeted endovascular revascularization is associated with superior wound healing and limb salvage compared with non-targeted revascularization in patients with diabetic foot ischemia. METHODS A retrospective single-center cohort study was conducted. All consecutive patients with diabetic foot ischemia undergoing endovascular revascularization at Hamad General Hospital, Hamad Medical Corporation, from January 2017 to March 2025 were included. Procedure types were classified into 3 groups: targeted-only (n = 33), non-targeted-only (n = 74), and combined targeted and non-targeted (n = 35). Primary outcomes were wound healing and limb salvage. Multivariable logistic regression was used to identify independent predictors of each outcome, with non-targeted-only as the reference group. RESULTS In total, 142 patients were analyzed (mean age 65.4 ± 12.0 years; 69.7% male). Technical success was significantly lower in the targeted-only group (69.7%) than in the non-targeted-only (91.9%) and combined (91.4%) groups (P = 0.005). No significant differences were observed in wound healing (48.5% vs 51.4% vs 41.2%; P = 0.617), limb salvage (75.8% vs 76.7% vs 80.0%; P = 0.903), or major amputation rates (P = 0.888). In multivariable analysis, procedure group was not an independent predictor of either limb salvage [area under the receiver-operating characteristic curve (AUC) = 0.661; model likelihood ratio P = 0.359] or wound healing (AUC = 0.770; P = 0.0001). Independent predictors of wound healing were older age [odds ratio (OR) = 1.05, 95% confidence interval (95%CI): 1.02–1.09; P = 0.004], lower Wagner grade (OR = 0.52, 95%CI: 0.32–0.86; P = 0.010), and longer follow-up (OR = 1.41, 95%CI: 1.13–1.76; P = 0.002). CONCLUSION This study, conducted in a country with a high prevalence of diabetes mellitus, found no statistically significant association between angiosome-targeted revascularization and wound healing or limb salvage compared with non-targeted revascularization. Wound severity and follow-up duration were the dominant predictors of clinical outcomes. These findings should be interpreted in the context of the study’s retrospective design and moderate sample size. Prospective multicenter studies are warranted.
Zitieren
APA
Zoghoul, S., Obeidat, M., Abdallah, E., Al-Hashemi, A., Shalaby, R., Al-Hashimi, I., El-Menyar, A., Al-Thani, H., Omar, A., & Barah, A. (2026). Angiosome-targeted vs non-targeted endovascular revascularization in diabetic foot ischemia: A retrospective cohort study. World Journal of Diabetes, 17(11). https://doi.org/10.4239/wjd.124667
Vancouver
Zoghoul S, Obeidat M, Abdallah E, Al-Hashemi A, Shalaby R, Al-Hashimi I, et al. Angiosome-targeted vs non-targeted endovascular revascularization in diabetic foot ischemia: A retrospective cohort study. World Journal of Diabetes. 2026;17(11). doi:10.4239/wjd.124667
BibTeX
@article{Zoghoul2026,
author = {Zoghoul, Sohaib and Obeidat, Mohammad and Abdallah, Elhassan and Al-Hashemi, Abdullah and Shalaby, Rana and Al-Hashimi, Israa and El-Menyar, Ayman and Al-Thani, Hassan and Omar, Ahmed and Barah, Ali},
title = {Angiosome-targeted vs non-targeted endovascular revascularization in diabetic foot ischemia: A retrospective cohort study},
journal = {World Journal of Diabetes},
year = {2026},
volume = {17},
number = {11},
doi = {10.4239/wjd.124667}
}
EUVIMED